Mediantechnologies Stock
Price
Target price
€3.90
€3.90
-0.890%
-0.035
-0.890%
-
03.10.24 / Stuttgart Stock Exchange
WKN: A1JCLB / Name: Median Tech / Stock / Software & IT Services / Micro Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Mediantechnologies Stock
Mediantechnologies shows a slight decrease today, losing -€0.035 (-0.890%) compared to yesterday.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Mediantechnologies stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Mediantechnologies in the next few years
Pros
?
B****
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Cons
?
S********** s********
?
C******** o* t** e**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Mediantechnologies vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Mediantechnologies | -0.890% | - | - | - | - | - | - |
| Coheris S.A. Inh. | 2.030% | 6.364% | 17.000% | 46.250% | 46.862% | 265.625% | 213.393% |
| Acteos | 0.410% | -1.619% | -6.897% | -10.000% | 4.292% | -45.516% | 15.166% |
| Prologue S.A. | 4.240% | -5.753% | -5.495% | -22.172% | -18.868% | -56.566% | -56.122% |
Comments
News
Median Technologies to Attend and Present at the ESMO Congress 2024, Being Held in Barcelona, Spain, from Sept 13-17, 2024
Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA/SME eligible, “Median” or “The Company”) announces today that the Company will attend the European Society for Medical Oncology
Median Technologies to share positive pivotal data for eyonis™ LCS diagnostic software as medical device at the IASLC 2024 World Conference on Lung Cancer
Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA/SME eligible, “Median” or “The Company”) announces today that the Company will be sharing information on its proprietary
Median Technologies to host two webcasts on September 5, 2024
Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA/SME eligible, “Median” or “The Company”) will host two live webcasts on September 5, 2024.
Following the recent release of